{"transactions":[{"id":1643266,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T16:03:57.000Z","date":"2024-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":99634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer Stock Option with an exercise price that is less than the Cash Amount was cancelled and converted into the right to receive (i) a cash payment equal to the product of (A) the excess, if any, of the Cash Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time and (ii) one CVR for each Share underlying such Issuer Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer Stock Option with an exercise price that is less than the Cash Amount was cancelled and converted into the right to receive (i) a cash payment equal to the product of (A) the excess, if any, of the Cash Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time and (ii) one CVR for each Share underlying such Issuer Stock Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer Stock Option with an exercise price that is less than the Cash Amount was cancelled and converted into the right to receive (i) a cash payment equal to the product of (A) the excess, if any, of the Cash Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time and (ii) one CVR for each Share underlying such Issuer Stock Option."}],"balance_after":0,"derivative":{"exercise_price":4.0347,"underlying":"Common Stock","underlying_shares":99634},"source":{"system":"sec-edgar","filing":"0001104659-24-023581","document":"tm246087-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000110465924023581/tm246087-7_4seq1.xml","form_type":"4"}},{"id":1643265,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-14T16:03:57.000Z","date":"2024-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of December 22, 2023, by and among the Issuer, Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\") and Concentra Merger Sub II, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of February 14, 2024 (the \"Effective Time\") with the Issuer surviving the merger."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Issuer restricted stock unit (\"Issuer RSU\") represents a contingent right to receive one Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each outstanding Issuer RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each Issuer RSU then outstanding was cancelled and converted into (i) a cash payment equal to the product of (A) the total number of Shares then underlying such Issuer RSU multiplied by (B) $4.05 per Share in cash (the \"Cash Amount\"), without interest and subject to any withholding of taxes; and (ii) one non-transferable contractual contingent value right per Share (each, a \"CVR\") subject to such Issuer RSU, which represents the right to receive potential payments, in cash, subject to any applicable tax withholding and without interest, all upon the terms and subject to the conditions as set forth in the Offer to Purchase, as amended, and in the related Letter of Transmittal."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each outstanding Issuer RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each Issuer RSU then outstanding was cancelled and converted into (i) a cash payment equal to the product of (A) the total number of Shares then underlying such Issuer RSU multiplied by (B) $4.05 per Share in cash (the \"Cash Amount\"), without interest and subject to any withholding of taxes; and (ii) one non-transferable contractual contingent value right per Share (each, a \"CVR\") subject to such Issuer RSU, which represents the right to receive potential payments, in cash, subject to any applicable tax withholding and without interest, all upon the terms and subject to the conditions as set forth in the Offer to Purchase, as amended, and in the related Letter of Transmittal."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each outstanding Issuer RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each Issuer RSU then outstanding was cancelled and converted into (i) a cash payment equal to the product of (A) the total number of Shares then underlying such Issuer RSU multiplied by (B) $4.05 per Share in cash (the \"Cash Amount\"), without interest and subject to any withholding of taxes; and (ii) one non-transferable contractual contingent value right per Share (each, a \"CVR\") subject to such Issuer RSU, which represents the right to receive potential payments, in cash, subject to any applicable tax withholding and without interest, all upon the terms and subject to the conditions as set forth in the Offer to Purchase, as amended, and in the related Letter of Transmittal."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001104659-24-023581","document":"tm246087-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000110465924023581/tm246087-7_4seq1.xml","form_type":"4"}},{"id":1857295,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-13T17:30:02.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.001 per share, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 9, 2024 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 9, 2024 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date. The RSUs have no expiration date."}],"balance_after":3250,"derivative":{"underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001745020-23-000039","document":"wk-form4_1686691788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000174502023000039/wk-form4_1686691788.xml","form_type":"4"}},{"id":1857294,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-13T17:30:02.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 9, 2024 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date."}],"balance_after":19500,"derivative":{"exercise_price":9.61,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001745020-23-000039","document":"wk-form4_1686691788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000174502023000039/wk-form4_1686691788.xml","form_type":"4"}},{"id":2234248,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T20:13:22.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 10, 2023 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":5.75,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-22-070663","document":"tm2218348-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000110465922070663/tm2218348-3_4seq1.xml","form_type":"4"}},{"id":2545522,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-08T19:00:20.000Z","date":"2021-10-06","kind":"grant","acquired":true,"shares":22678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/36th of the options vesting monthly after October 6, 2021, subject to the Reporting Person's continuous service with the issuer."}],"balance_after":22678,"derivative":{"exercise_price":16,"expiration_date":"2031-10-05","underlying":"Common Stock","underlying_shares":22678},"source":{"system":"sec-edgar","filing":"0000899243-21-039758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924321039758/doc4.xml","form_type":"4"}},{"id":2876837,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-05T18:42:24.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":216718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on February 3, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":216718,"derivative":{"exercise_price":12.7,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":216718},"source":{"system":"sec-edgar","filing":"0000899243-21-005091","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924321005091/doc4.xml","form_type":"4"}},{"id":2997508,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-30T20:19:44.000Z","date":"2020-10-28","kind":"grant","acquired":true,"shares":78534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of this option shall vest and become exercisable on October 28, 2022, with the remainder vesting in two (2) equal annual installments thereafter."}],"balance_after":78534,"derivative":{"exercise_price":9.88,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":78534},"source":{"system":"sec-edgar","filing":"0000899243-20-030033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805387/000089924320030033/doc4.xml","form_type":"4"}},{"id":3522090,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T21:41:40.000Z","date":"2019-05-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":125000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-031065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119031065/doc4.xml","form_type":"4"}},{"id":3522089,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-05-17T21:41:40.000Z","date":"2019-05-15","kind":"sale","acquired":false,"shares":5000,"price":10,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,833 shares subject to restricted stock units granted on January 24, 2018 that will vest in two (2) remaining equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates.  Additionally, this amount includes 19,250 shares subject to restricted stock units granted on February 25, 2019 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates."}],"balance_after":25512,"source":{"system":"sec-edgar","filing":"0001209191-19-031065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119031065/doc4.xml","form_type":"4"}},{"id":3522088,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-05-17T21:41:40.000Z","date":"2019-05-15","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":30512,"source":{"system":"sec-edgar","filing":"0001209191-19-031065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119031065/doc4.xml","form_type":"4"}},{"id":3555315,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-16T23:27:45.000Z","date":"2019-04-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":130000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-024836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119024836/doc4.xml","form_type":"4"}},{"id":3555314,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-16T23:27:45.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":5000,"price":12.11,"value":60550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,833 shares subject to restricted stock units granted on January 24, 2018 that will vest in two (2) remaining equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates.  Additionally, this amount includes 19,250 shares subject to restricted stock units granted on February 25, 2019 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates."}],"balance_after":25512,"source":{"system":"sec-edgar","filing":"0001209191-19-024836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119024836/doc4.xml","form_type":"4"}},{"id":3555313,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-16T23:27:45.000Z","date":"2019-04-15","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":30512,"source":{"system":"sec-edgar","filing":"0001209191-19-024836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119024836/doc4.xml","form_type":"4"}},{"id":3591360,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-18T23:35:20.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":135000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-020126","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119020126/doc4.xml","form_type":"4"}},{"id":3591359,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-18T23:35:20.000Z","date":"2019-03-15","kind":"sale","acquired":false,"shares":5000,"price":10,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,833 shares subject to restricted stock units granted on January 24, 2018 that will vest in two (2) remaining equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates.  Additionally, this amount includes 19,250 shares subject to restricted stock units granted on February 25, 2019 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates."}],"balance_after":25512,"source":{"system":"sec-edgar","filing":"0001209191-19-020126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119020126/doc4.xml","form_type":"4"}},{"id":3591358,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-18T23:35:20.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":30512,"source":{"system":"sec-edgar","filing":"0001209191-19-020126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119020126/doc4.xml","form_type":"4"}},{"id":3615185,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-06T01:21:54.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":140000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-017164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119017164/doc4.xml","form_type":"4"}},{"id":3615184,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-06T01:21:54.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":5000,"price":10,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,833 shares subject to restricted stock units granted on January 24, 2018 that will vest in two (2) remaining equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates.  Additionally, this amount includes 19,250 shares subject to restricted stock units granted on February 25, 2019 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates."}],"balance_after":25512,"source":{"system":"sec-edgar","filing":"0001209191-19-017164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119017164/doc4.xml","form_type":"4"}},{"id":3615183,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-06T01:21:54.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":30512,"source":{"system":"sec-edgar","filing":"0001209191-19-017164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119017164/doc4.xml","form_type":"4"}},{"id":3629922,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (Right-to-Buy)","published_at":"2019-02-28T01:18:30.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":115500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 25, 2019 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":115500,"derivative":{"exercise_price":9.03,"expiration_date":"2029-02-24","underlying":"Common Stock","underlying_shares":115500},"source":{"system":"sec-edgar","filing":"0001209191-19-014297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119014297/doc4.xml","form_type":"4"}},{"id":3629921,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-28T01:18:30.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":19250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents 19,250 shares subject to restricted stock units granted on February 25, 2019 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date.  Additionally, this amount includes 4,833 shares subject to restricted stock units granted on January 24, 2018 that will vest in two (2) remaining equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates."}],"balance_after":25512,"source":{"system":"sec-edgar","filing":"0001209191-19-014297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119014297/doc4.xml","form_type":"4"}},{"id":3685834,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-28T22:45:54.000Z","date":"2019-01-24","kind":"tax_withholding","acquired":false,"shares":988,"price":11.1,"value":10966.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of the restricted stock unit grant that vested on January 24, 2019 surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on January 24, 2019 of $11.10/share, pursuant to the terms of the Issuer's 2013 Stock Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,429 shares resulting from the January 24, 2019 vesting of Reporting Person's January 24, 2018 restricted stock unit grant and 4,833 shares subject to such restricted stock unit grant that will vest in two (2) additional equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":6262,"source":{"system":"sec-edgar","filing":"0001209191-19-005619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119005619/doc4.xml","form_type":"4"}},{"id":3694855,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-16T21:08:37.000Z","date":"2019-01-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":145000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-003926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119003926/doc4.xml","form_type":"4"}},{"id":3694854,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-16T21:08:37.000Z","date":"2019-01-15","kind":"sale","acquired":false,"shares":5000,"price":11.04,"value":55200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-19-003926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119003926/doc4.xml","form_type":"4"}},{"id":3694853,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-16T21:08:37.000Z","date":"2019-01-15","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-19-003926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119003926/doc4.xml","form_type":"4"}},{"id":3727755,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-18T22:35:40.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":150000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-063265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118063265/doc4.xml","form_type":"4"}},{"id":3727754,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-18T22:35:40.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":5000,"price":11.44,"value":57200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-063265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118063265/doc4.xml","form_type":"4"}},{"id":3727753,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-18T22:35:40.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-063265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118063265/doc4.xml","form_type":"4"}},{"id":3762155,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-16T22:16:08.000Z","date":"2018-11-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":155000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-059015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118059015/doc4.xml","form_type":"4"}},{"id":3762154,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-16T22:16:08.000Z","date":"2018-11-15","kind":"sale","acquired":false,"shares":5000,"price":10,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-059015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118059015/doc4.xml","form_type":"4"}},{"id":3762153,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-16T22:16:08.000Z","date":"2018-11-15","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-059015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118059015/doc4.xml","form_type":"4"}},{"id":3790081,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-16T23:25:23.000Z","date":"2018-10-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":160000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-055200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118055200/doc4.xml","form_type":"4"}},{"id":3790080,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-16T23:25:23.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":5000,"price":13.97,"value":69850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-055200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118055200/doc4.xml","form_type":"4"}},{"id":3790079,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-16T23:25:23.000Z","date":"2018-10-15","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-055200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118055200/doc4.xml","form_type":"4"}},{"id":3813477,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-18T21:06:18.000Z","date":"2018-09-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":165000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-051500","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118051500/doc4.xml","form_type":"4"}},{"id":3813476,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-09-18T21:06:18.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":5000,"price":14.6569,"value":73284.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $14.50 to $14.95. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-051500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118051500/doc4.xml","form_type":"4"}},{"id":3813475,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-09-18T21:06:18.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-051500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118051500/doc4.xml","form_type":"4"}},{"id":3840640,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-17T20:17:53.000Z","date":"2018-08-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":170000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-047359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118047359/doc4.xml","form_type":"4"}},{"id":3840639,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-17T20:17:53.000Z","date":"2018-08-16","kind":"sale","acquired":false,"shares":5000,"price":15.3903,"value":76951.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $15.20 to $15.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-047359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118047359/doc4.xml","form_type":"4"}},{"id":3840638,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-17T20:17:53.000Z","date":"2018-08-16","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-047359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118047359/doc4.xml","form_type":"4"}},{"id":3866633,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-17T20:16:49.000Z","date":"2018-07-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":175000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-042845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118042845/doc4.xml","form_type":"4"}},{"id":3866632,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-17T20:16:49.000Z","date":"2018-07-16","kind":"sale","acquired":false,"shares":5000,"price":14.772,"value":73860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $14.45 to $15.10. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-042845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118042845/doc4.xml","form_type":"4"}},{"id":3866631,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-17T20:16:49.000Z","date":"2018-07-16","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-042845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118042845/doc4.xml","form_type":"4"}},{"id":3892938,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T23:43:12.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":180000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-038208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118038208/doc4.xml","form_type":"4"}},{"id":3892937,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-15T23:43:12.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":5000,"price":15.673,"value":78365.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $15.45 to $15.825. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-038208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118038208/doc4.xml","form_type":"4"}},{"id":3892936,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-15T23:43:12.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-038208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118038208/doc4.xml","form_type":"4"}},{"id":3931602,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-16T22:38:05.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":185000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-030691","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118030691/doc4.xml","form_type":"4"}},{"id":3931601,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-16T22:38:05.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":5000,"price":15.384,"value":76920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $15.20 to $15.55. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-030691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118030691/doc4.xml","form_type":"4"}},{"id":3931600,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-16T22:38:05.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-030691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118030691/doc4.xml","form_type":"4"}},{"id":3961416,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-18T20:04:03.000Z","date":"2018-04-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 27, 2017, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":190000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-025351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118025351/doc4.xml","form_type":"4"}},{"id":3961415,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-18T20:04:03.000Z","date":"2018-04-16","kind":"sale","acquired":false,"shares":5000,"price":19.8288,"value":99144.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $19.45 to $20.40 The Reporting Person will provide upon request to the SEC, the issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-025351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118025351/doc4.xml","form_type":"4"}},{"id":3961414,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-18T20:04:03.000Z","date":"2018-04-16","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-025351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118025351/doc4.xml","form_type":"4"}},{"id":3993407,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-16T23:41:59.000Z","date":"2018-03-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 27, 2017 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":195000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-020419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118020419/doc4.xml","form_type":"4"}},{"id":3993406,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-16T23:41:59.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":5000,"price":25.5624,"value":127812.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $25.40 to $25.80 The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-020419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118020419/doc4.xml","form_type":"4"}},{"id":3993405,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-16T23:41:59.000Z","date":"2018-03-15","kind":"exercise","acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"balance_after":12250,"source":{"system":"sec-edgar","filing":"0001209191-18-020419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118020419/doc4.xml","form_type":"4"}},{"id":4083867,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-01T01:11:36.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":43500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares vest and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 24, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":43500,"derivative":{"exercise_price":20.05,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":43500},"source":{"system":"sec-edgar","filing":"0001209191-18-006339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118006339/doc4.xml","form_type":"4"}},{"id":4083866,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-01T01:11:36.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001209191-18-006339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118006339/doc4.xml","form_type":"4"}},{"id":4411126,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":94302,"kind":"person","name":"Yi Kathy","position":1,"cik":"0001697802","reported_name":"Yi Kathy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-02T22:15:44.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from February 27, 2017, and the balance of the shares will vest and become exercisable in 36 equal monthly installments upon her completion of each additional month of service thereafter."}],"balance_after":200000,"derivative":{"exercise_price":4.55,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001140361-17-010313","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000114036117010313/doc1.xml","form_type":"4"}}]}